Cleared Traditional

K953291 - QUANTA LITE ACA SCREEN (HRP)

K953291 is the FDA 510(k) clearance for QUANTA LITE ACA SCREEN (HRP) by Inova Diagnostics, Inc.. It is a Class 2 Immunology device (product code MID) cleared through the Traditional 510(k) pathway after a 46-day FDA review.

K953291 · Inova Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1995
Decision
46d
Days
Class 2
Risk

K953291 is an FDA 510(k) clearance for the QUANTA LITE ACA SCREEN (HRP). Classified as System, Test, Anticardiolipin Immunological (product code MID), Class II - Special Controls.

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on August 29, 1995 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Inova Diagnostics, Inc. devices

Submission Details

510(k) Number K953291 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 14, 1995
Decision Date August 29, 1995
Days to Decision 46 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 104d · This submission: 46d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MID System, Test, Anticardiolipin Immunological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5660
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - MID System, Test, Anticardiolipin Immunological

All 45
Devices cleared under the same product code (MID) and FDA review panel - the closest regulatory comparables to K953291.
HEMAGEN ANTI CARDIOLIPIN SCREEN
K971039 · Hemagen Diagnostics, Inc. · Jun 1997
VARELISA CARDIOLIPIN ABS SCREEN
K951187 · Elias U.S.A., Inc. · Oct 1995
QUANTA LITE IGA ACA (HRP)
K953366 · Inova Diagnostics, Inc. · Sep 1995
QUANTA LITE(TM) IGG (HRP)
K946034 · Inova Diagnostics, Inc. · Jul 1995
QUANTA LITE ACA IGM (HRP)
K946385 · Inova Diagnostics, Inc. · Jul 1995
ANTI-CARDIOLIPIN ANTIBODY (IGA-ACA)TEST)
K933784 · Immco Diagnostics, Inc. · Mar 1995